Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1CNS 1

Conditions

Sarcoma 168Gliosarcoma 134Glioblastoma 130Brain Neoplasms 101Astrocytoma 86Central Nervous System Neoplasms 77Osteosarcoma 65Oligodendroglioma 61Neuroblastoma 58Sarcoma, Kaposi 56Glioma 51Neuroectodermal Tumors, Primitive, Peripheral 48Dendritic Cell Sarcoma, Interdigitating 44Burkitt Lymphoma 44Rhabdomyosarcoma 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Neoplasms 40Lymphoma 39Wilms Tumor 37Medulloblastoma 35Lymphoma, Non-Hodgkin 35Recurrence 32Sarcoma, Ewing 31Acquired Immunodeficiency Syndrome 30Lymphoma, Large B-Cell, Diffuse 29HIV Infections 29Ependymoma 28Leukemia 27Gastrointestinal Stromal Tumors 27Melanoma 26

Interventions

Dexamethasone 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenoma, Acidophil × Sarcoma × Clear all
NCT01088763 2014-11-05

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
129 enrolled
CNSEndocrineLymphoidOther hematologic neoplasmSarcoma

Familial ependymoma, Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Oligodendroglioma, Pituitary Neoplasms, Recurrence, Spinal Cord Neoplasms, Prolactinoma, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Rhabdoid Tumor, Optic Nerve Glioma, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡